Company News & Press

Media, Press, and other Proxima Company Updates

Renata Medical Receives FDA Approval for the Minima Growth Stent, First-of-its-Kind Device for Treating Aortic Coarctation and Pulmonary Artery Stenosis

CDS: Is Your Clinical Decision Support Software a Medical Device?

Proxima Receives Dual Honors: Inc 5000 Listing & Platinum dotCOMM Award

FDA Approves Groundbreaking Oral Solution for Postpartum Depression

Isabella Schmitt Weighs In On IoT Innovation In Recent CMSWire Feature

Proxima VP of Life Science Solutions Listed in '3 Innovators to Know this Week'

Unveiling Houston's Potential: Isabella Schmitt Featured in Houston Innovation Map

Proxima Clinical Research Expands Office Space and Business in 2023

Proxima Clinical Research Launches Early Phase Oncology Network for New Investigational Therapies

ANEUVO Launches US Study of ExaStim a Non-invasive Spinal Neuromodulation System

Proxima Clinical Research Named to Inc. Best in Business List

Vision board challenges | January 5th, 2023

Proxima Newsletter

Rants, raves and observations.
Occasionally an opinion or fact.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Expertise

Resources

Company

Company Updates

Connect

2450 Holcombe Blvd.
Houston, TX 77021

Hello@ProximaCRO.com
+1.936.463.2221‬

Proxima Clinical Research, Inc. (aka Proxima CRO) is a registered Delaware C Corp, headquartered in Houston, TX
© Copyright 2024 Proxima Clinical Research, Inc. All Rights Reserved.